Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate for Cardiac Anesthesia
NCT06717945Phase 1Not yet recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of remimazolam in Anesthesia (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: ratio of successful sedation during the whole surgery. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT06717945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717945.